Real-world utilization of cabotegravir plus rilpivirine in Southern Spain: data from the CARIPLA study

被引：0
|
作者：
Palacios, Rosario [1 ]
Gomez-Ayerbe, Cristina [1 ]
Mayorga, Marisa [2 ]
Espinosa, Nuria [3 ]
Hidalgo, Alicia [4 ]
Tellez, Francisco [5 ]
Lozano, Ana Belen [6 ]
Loring, Monica
Santos, Jesus [1 ,7 ]
机构：
[1] Hosp Univ Virgen Victoria, Infect Dis Unit, Malaga, Spain
[2] Hosp Reg Carlos Haya, Infect Dis Unit, Malaga, Spain
[3] Hosp Virgen Rocio, Infect Dis Unit, Seville, Spain
[4] Hosp Juan Ramon Jimenez, Infect Dis Unit, Huelva, Spain
[5] Hosp Puerto Real, Infect Dis, Cadiz, Spain
[6] Hosp El Ejido, Infect Dis Unit, Almeria, Spain
[7] Hosp Axarquia, Internal Med, Malaga, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P084
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [41] Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
    Kocher, Florian
    Seeber, Andreas
    Weiss, Lukas
    Romeder, Franz
    Szkandera, Joanna
    Kuhr, Thomas
    Kostner, Susanne
    Pichler, Petra
    Jaeger, Thomas
    Greil, Richard
    Brodowicz, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir plus Rilpivirine Long-Acting Into European Clinical Settings
    Jonsson-Oldenbuettel, Celia
    Ghosn, Jade
    van der Valk, Marc
    Florence, Eric
    Vera, Francisco
    De Wit, Stephane
    Rami, Agathe
    Bonnet, Fabrice
    Hocqueloux, Laurent
    Hove, Kai
    Ait-Khaled, Mounir
    DeMoor, Rebecca
    Bontempo, Gilda
    Latham, Christine L.
    Gutner, Cassidy A.
    Iyer, Supriya
    Gill, Martin
    Czarnogorski, Maggie
    D'Amico, Ronald
    van Wyk, Jean
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (05) : 472 - 480
  • [43] Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)
    Rodriguez-Nieto, Maria Jesus
    Cano-Jimenez, Esteban
    Romero Ortiz, Ana D.
    Villar, Ana
    Morros, Marta
    Ramon, Alba
    Armengol, Silvia
    PHARMACOECONOMICS, 2023, 41 (08) : 999 - 1010
  • [44] Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)
    Maria Jesus Rodríguez-Nieto
    Esteban Cano-Jiménez
    Ana D. Romero Ortiz
    Ana Villar
    Marta Morros
    Alba Ramon
    Silvia Armengol
    PharmacoEconomics, 2023, 41 : 999 - 1010
  • [45] A Study of Real-World Data Races in Golang
    Chabbi, Milind
    Ramanathan, Murali Krishna
    PROCEEDINGS OF THE 43RD ACM SIGPLAN INTERNATIONAL CONFERENCE ON PROGRAMMING LANGUAGE DESIGN AND IMPLEMENTATION (PLDI '22), 2022, : 474 - 489
  • [46] Migraine treatment: quo vadis? Real-world data study (2015-2022) in Spain
    Pozo-Rosich, Patricia
    Carmo, Mafalda
    Muniz, Alejandro
    Armada, Beatriz
    Moya-Alarcon, Carlota
    Pascual, Julio
    BMC NEUROLOGY, 2024, 24 (01)
  • [47] A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN
    Ramos-Quiroga, J. A.
    Tang, J. P.
    Solozabal, M.
    De Prado, A.
    Minarro, C.
    Callejo-Velasco, D.
    VALUE IN HEALTH, 2019, 22 : S760 - S760
  • [48] Real-World Data from a Spanish Institution
    Zwisler-Contreras, P.
    Ramos, I.
    Guardamagna, M.
    Ithurbisquy, C.
    Oliva, L.
    Ruiz, S.
    Alba, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S580 - S581
  • [49] Data of Daratumumab from a Real-World Single-Center Study
    Wang, Jun
    Wu, Jiafei
    Yang, Xi
    Zheng, Hong
    Wang, Yijing
    Zheng, Boyue
    Li, Feiyang
    Li, Hui
    BLOOD, 2022, 140 : 12650 - 12650
  • [50] Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119
    Palacios, R.
    Gomez-Ayerbe, C.
    Casado, J. L.
    Tejerina, F.
    Montes, M. L.
    Castano, M.
    Ocampo, A.
    Rial, D.
    Ribera, E.
    Galindo, M. J.
    Hidalgo, C.
    Farinas, C.
    Montero, M.
    Payeras, T.
    Fanjul, F.
    de la Torre, J.
    Santos, J.
    HIV MEDICINE, 2023, 24 (08) : 933 - 937
12345